Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method

Drug Development and Industrial Pharmacy

Volumn 34, Issue 3, 2008, Pages 314-322

  Chingunpitak, Jiraporn ^a   Puttipipatkhachorn, Satit ^a   Chavalitshewinkoon Petmitr, Porntip ^a   Tozuka, Yuichi ^b   Moribe, Kunikazu ^c   Yamamoto, Keiji ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Co grinding; Dihydroartemisinin; Nanoparticles; Nanosuspension

Indexed keywords

DEOXYCHOLATE SODIUM; DIHYDROARTEMISININ; NANOCRYSTAL; NANOPARTICLE; POVIDONE;

ADSORPTION; ANTIMALARIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; DIFFRACTION; DRUG SOLUBILITY; DRUG STRUCTURE; GRINDING; MEASUREMENT; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; PLASMODIUM FALCIPARUM; SUSPENSION; TIME; TRANSMISSION ELECTRON MICROSCOPY; VIBRATION; ZETA POTENTIAL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CRYSTALLIZATION; DEOXYCHOLIC ACID; DRUG STABILITY; EXCIPIENTS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PLASMODIUM FALCIPARUM; POVIDONE; SESQUITERPENES; SOLUBILITY; SUSPENSIONS;

EID: 41149114651     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701662388     Document Type: Article

References (42)

1. Burry, R., Desmazières, B., & Treiner, C. (1997). Interaction between poly(vinylpyrrolidone) and ionic surfactants at various solid/water interfaces: A calorimetric investigation. Colloid. Surf. A: Physicochem. Eng. Aspects, 127, 113-124.
2. th Indochina Conference on Pharmaceutical Sciences. Ho Chi Minh City, Vietnam, 11-13 November 2005.
3. th Asian Congress of Pharmaceutical Sciences. Bangkok, Thailand, 30 November-3 December 2004.
4. Desjarardins, R. E., Canfield, C. J., Haynes, J. D.,& Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother., 16, 710-718.
5. Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm., 299, 167-177.
6. Itoh, K., Pongpeerapat, A., Tozuka, Y., Oguchi, T., & Yamamoto, K. (2003). Nanoparticle formation of poorly water soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull., 51, 171-174.
7. Jacobs, C., Kayser, O., & Müller, R. H. (2001). Production and characterization of mucoadhesive nanosuspensions for the formulation of bupravaquone. Int. J. Pharm., 214, 3-7.
8. Jones, M. N. (1999). Surfactants in membrane solubilization. Int. J. Pharm., 177, 137-159.
9. Kipp, J. E., Wong, J. C. T., Doty, M. J., & Rebbeck, C. L. (2003). U.S. Patent No 6,607,784. Microprecipitation method for preparing submicron suspensions.
10. Kirkpatrick, F. H., Gordesky S. E., & Marinetti, G. V. (1974). Differential solubilization of proteins, phospholipids and cholesterol of erythrocyte membranes by detergents. Biochim. Biophys. Acta., 345, 154-161.
11. Kocbek, P., Baumgartner, S., & Kristl, J. (2006). Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drug. Int. J. Pharm., 312, 179-186.
12. Kondo, N., Iwao, T., Masuda, H., Yamanouchi, K., Ishihara, Y., Yamada, N., Haga, T., Ogawa, Y., & Yokoyama, K. (1993). Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. Chem. Pharm. Bull., 41, 737-740.
13. Liversidge, G. G., & Conzentino, P. (1995). Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm., 125, 309-313.
14. Liversidge, G. G., Cundy, K. C., Bishop, J. F., & Czekai, D. A. (1992). U.S. Patent No 5,145,684. Surface modified drug nanoparticles.
15. Liversidge, G., Jenkins, S., & Liversidge, E. (2006a). U.S. Patent No 2006188566. Nanoparticulate formulations of docetaxel and analogues.
16. Liversidge, G.G., & Jenkins, S. (2006b). U.S. Patent No 2006210638. Injectable compositions of nanoparticulate immunosuppressive compounds.
17. Luo, X. D., & Shen, C. C. (1987). The chemistry, pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev., 7, 29-52.
18. Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R., & Kissel, T. (2005). Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res., 22, 2058-2068.
19. Moribe, K., Pongpeerapat, A., Tozuka, Y., & Yamamoto, K. (2006). Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures. Pharmazie., 61, 97-101.
20. Möschwitzer, J., Achleitner, G., Pomper, H., & Müller, R. H. (2004). Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur. J. Pharm. Biopharm., 58, 615-619.
21. Müller, R. H., Jacobs, C., & Kayer, O. (2000). Nanosuspensions for the formulation of poorly soluble drugs. In F. Nielloud & G. Marti-Mestres (Eds.), Pharmaceutical emulsion and suspension (pp. 383-407). New York: Marcel Dekker.
22. Myint, P. T., & Shwe, T. (1987). A controlled clinical trial of artemeter (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Tran. R. Soc. Trop. Med. Hyg., 81, 559-561.
23. Myint, P. T., Shwe, T., Soe, L., Htut, Y., & Myint, W. (1989). Clinical study of the treatment of cerebral malaria with artemeter (qinghaosu derivative). Tran. R. Soc. Trop. Med. Hyg., 83, 72.
24. Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004). Nanosuspension: A promising drug delivery strategy. J. Pharm. Pharmacol., 56, 827-840.
25. Pongpeerapat, A., Itoh, K., Tozuka, Y., Moribe, K., Oguchi, T., & Yamamoto, K. (2004). Formation and stability of drug nanoparticles obtained from drug/PVP/SDS ternary ground mixture. J. Drug Del. Sci. Tech., 14, 441-447.
26. th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, 27-30 March 2006.
27. Rabinow, B. E. (2004). Nanosuspensions in drug delivery. Nat. Rev. Drug Discov., 3, 785-796.
28. Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Controlled Release, 82(1), 105-114.
29. Sethabouppha, B. (1999). Dissolution improvement of dihydroartemisinin capsules and tablets, Master's thesis, Mahidol University, Bangkok, Thailand.
30. Sugimoto, M., Okagaki, T., Narisawa, S., Koida, Y., & Nakajima, K. (1998). Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm., 160, 11-19.
31. Suzuki, H., Ogawa, M., Hironaka, K., Ito, K., & Sunada, H. (2001). A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev. Ind. Pharm., 27, 951-958.
32. Terayama, H., Okumura, K., Sakai, K., Torigoe, K., & Esumi, K. (2001). Aqueous dispersion behavior of drug particles by addition of surfactant and polymer. Colloid. Surf. B: Biointerfaces, 20, 73-77.
33. Titulaer, H. A. C., Zuidema, J., & Lugt, C. B. (1991). Formulation and pharmacokinetics of artemisinin and its derivatives. Int. J. Pharm., 69, 83-92.
34. Tozuka, Y., Wongmekiat, A., Sakata, K., Moribe, K., Oguchi, T., & Yamamoto, K. (2004). Co-grinding with cyclodextrin as a nanoparticle preparation method of a poorly water soluble drug. J. Incl. Phenom. Macrocycl. Chem., 50, 67-71.
35. Trager, W., & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science., 193, 673-675.
36. Trotta, M., Gallarate, M., Carlotti, M. E., & Morel, S. (2005). Preparation of griseofulvin nanoparticles from water dilutable microemulsions. Int. J. Pharm., 254, 235-242.
37. Trotta, M., Gallarete, M., Pattarino, F., & Morel, S. (2001). Emulsions containing partially water-miscible solvents for the preparation of dry nanosuspensions. J. Control. Release., 76, 119-128.
38. Wilairatana, P., Chanthavanich, P., Singhasivanon, P., Treeprasertsuk, S., Krudsook, S., Chalermrut, K., Phisalaphong, C., Kraisintu, K., & Looareesuwan, S. (1998). A comparison of three different dihydroartemisinin formulations for the treatment of acute uncomplicated falciparum malaria in Thailand. Int. J. Parasitol., 28, 1213-1218.
39. Wongmekiat, A., Tozuka, Y., Oguchi, T., & Yamamoto, K. (2002). Formation of fine drug particles by co-grinding with cyclodextrin. I. The use of β-cyclodextrin anhydrate and hydrate. Pharm. Res., 19, 1867-1872.
40. Wongmekiat, A., Tozuka, Y., Oguchi, T., & Yamamoto, K. (2003). Formation of fine drug particle by cogrinding with cyclodextrins. Part II. The influence of moisture condition during cogrinding process on fine particle formation. Int. J. Pharm., 265, 85-93.
41. World Health Organization (2002). Annual report, Thailand.
42. Zili, Z., Sfar, S., & Fessi, H. (2005). Preparation and characterization of poly-ε-carprolactone nanoparticles containing griseofulvin. Int. J. Pharm., 294, 261-267.